Toxicology and biodistribution study of CIGB-230, a DNA vaccine against hepatitis C virus

Human and Experimental Toxicology

Volumn 28, Issue 8, 2009, Pages 479-491

  Bacardí, Dania ^a   Amador Cañizares, Yalena ^a   Cosme, Karelia ^a   Urquiza, Dioslaida ^a   Suárez, José ^a   Marante, Jeny ^a   Viña, Ariel ^a   Vázquez, Ariel ^a   Concepción, Joel ^a   Pupo, Maylín ^a   Aldana, Lizet ^a   Soria, Yordanka ^a   Romero, Juan ^a   Madrigal, Roberto ^a   Martínez, Leticia ^a   Hernández, Lourdes ^a   González, Idania ^a   Dueñas Carrera, Santiago ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

DNA vaccine; HCV; Systemic effects; Tissue; Toxicity

Indexed keywords

CIGB 230; DNA VACCINE; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SAFETY; FEMALE; FOOD INTAKE; HEMATOLOGICAL PARAMETERS; HEPATITIS C; IMMUNOGENICITY; MALE; MORTALITY; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; FEMALE; HEPACIVIRUS; HEPATITIS ANTIGENS; HEPATITIS C; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOXICITY TESTS; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES;

ANIMALIA; HEPATITIS C VIRUS; MIRIDAE; MUS; RATTUS;

EID: 70349687252     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327109106438     Document Type: Article

References (47)

1. Ada, G., Ramshaw, I. DNA vaccination. Expert Opin Emerg Drugs 2003 ; 8: 27 - 35.
2. Lowrie, DB DNA vaccination: an update. Methods Mol Med 2003 ; 87: 377 - 390.
3. Ugen, KE, Nyland, SB, Boyer, JD, Vidal, C., Lera, L., Rasheid, S., et al. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 1998 ; 16: 1818 - 1821.
4. Donnelly, J., Berry, K., Ulmer, JB Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 2003 ; 33: 457 - 467.
5. Bureau, MF, Naimi, S., Torero, IR, Seguin, J., Georger, C., Arnould, E., et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004 ; 1676: 138 - 148.
6. Tuomela, M., Malm, M., Wallen, M., Stanescu, I., Krohn, K., Peterson, P. Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method. Vaccine 2005 ; 23: 890 - 896.
7. Pal, R., Yu, Q., Wang, S., Kalyanaraman, VS, Nair, BC, Hudacik, L., et al. Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits. Vaccine 2006 ; 24: 1225 - 1234.
8. Coelho-Castelo, AA, Trombone, AP, Rosada, RS, Santos Jr, RR, Bonato, VL, Sartori, A., et al. Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery. Genet Vaccines Ther 2006 ; 4: 1.
9. Jechlinger, W. Optimization and delivery of plasmid DNA for vaccination. Expert Rev Vaccines 2006 ; 5: 803 - 825.
10. Jeong, GJ, Byun, HM, Kim, JM, Yoon, H., Choi, HG, Kim, WK, et al. Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure. J Control Release 2007 ; 118: 118 - 125.
11. Perrie, Y., McNeil, S., Vangala, A. Liposome-mediated DNA immunisation via the subcutaneous route. J Drug Target 2003 ; 11: 555 - 563.
12. Xiang, JJ, Tang, JQ, Zhu, SG, Nie, XM, Lu, HB, Shen, SR, et al. IONP-PLL: a novel non-viral vector for efficient gene delivery. J Gene Med 2003 ; 5: 803 - 817.
13. Bhavsar, MD, Amiji, MM Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 2007 ; 119: 339 - 348.
14. Jung, HJ, Hwang, DS, Wei, QD, Cha, HJ Carassius auratus-originated recombinant histone H1 C-Terminal peptide as gene delivery material. Biotechnol Prog 2008 ; 24: 17 - 22.
15. Box, M., Parks, DA, Knight, A., Hale, C., Fishman, PS, Fairweather, NF A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells. J Drug Target 2003 ; 11: 333 - 343.
16. Puebla, I., Esseghir, S., Mortlock, A., Brown, A., Crisanti, A., Low, W. A recombinant H1 histone-based system for efficient delivery of nucleic acids. J Biotechnol 2003 ; 105: 215 - 226.
17. Dueñas-Carrera, S., Alvarez-Lajonchere, L., Cesar Alvarez-Obregon, J., Perez, A., Acosta-Rivero, N., Vazquez, DM, et al. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids. Biotechnol Appl Biochem 2002 ; 35: 205 - 212.
18. Lorenzo, LJ, Dueñas-Carrera, S., Falcon, V., Acosta-Rivero, N., Gonzalez, E., de la Rosa, MC, et al. Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli. Biochem Biophys Res Commun 2001 ; 281: 962 - 965.
19. Acosta-Rivero, N., Aguilera, Y., Falcon, V., Poutou, J., Musacchio, A., Alvarez-Lajonchere, L., et al. Ultrastructural and immunological characterization of hepatitis C core protein-dna plasmid complexes. Am J Immunol 2006 ; 2: 67 - 72.
20. Alvarez-Lajonchere, L., Gonzalez, M., Alvarez-Obregon, JC, Guerra, I., Vina, A., Acosta-Rivero, N., et al. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice. Biotechnol Appl Biochem 2006 ; 44: 9 - 17.
21. Limonta, M., Marquez, G., Rey, I., Pupo, M., Ruiz, O., Amador-Cañizares, Y., et al. Plasmid DNA recovery using size-exclusion and perfusion chromatography. Biopharm Int 2008 ; 21: 38 - 48.
22. Dueñas-Carrera, S., Morales, J., Acosta-Rivero, N., et al. Variable level expression of hepatitis C virus core protein in a prokaryotic system. Analysis of the humoral response in rabbit. Biotecnologóa Aplicada 1999 ; 16: 226 - 231.
23. Acosta-Rivero, N., Rodriguez, A., Mussachio, A., Poutou, J., Falcon, V., Torres, D., et al. A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids. Biochem Biophys Res Commun 2005 ; 334: 901 - 906.
24. Herrera, AM, Rodriguez, EG, Hernandez, T., Sandez, B., Duarte, CA A family of compact plasmid vectors for DNA immunization in humans. Biochem Biophys Res Commun 2000 ; 279: 548 - 551.
25. European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. Strasbourg: Council of Europe ; (ETS 123 of 1986).
26. Directive 2004/10/EC of the European Parliament and of the Council. On the harmonization of laws, regulations and administrative provisions relating to the application of the principle of good laboratory practice and the verification of their applications for test on chemical substances. Official Journal of the European Union: L 50/44-L 50/59, 2004.
27. EEC. Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Offical Journal of the European Communities 1986; L358: 1-29.
28. NRC. National Research Council. Animal alternatives, welfare and ethics. In: van Zutphen, LFM, Balls, M, (eds), Developments in animal and veterinary sciences. 1997, Elsevier Science, New York: 291 - 296.
29. Euroguide. On the accommodation and care of animals used for experimental and other purposes. FELASA ; 2007, Royal Society of Medicine Press Ltd., London, UK.
30. CPMP/ICH/286/95. No-clinical safety studies for the conduct of human clinical trials for pharmaceuticals. ICH M3 (M), 2000.
31. CPMP/SWP/1042/99. Note for guidance on repeated dose toxicity. 2000.
32. Regulation No. 39/04 from The National Regulatory Agency (CECMED) that rules scientific procedures on animals in Cuba, GPL of non Clinical Laboratory of sanitary safety and environmental, 2004.
33. Triozzi, PL, Aldrich, W., Allen, KO, Carlisle, RR, LoBuglio, AF, Conry, RM Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse. J Immunother 2005 ; 28: 382 - 388.
34. Martin, JE, Pierson, TC, Hubka, S., Rucker, S., Gordon, IJ, Enama, ME, et al. A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. J Infect Dis 2007 ; 196: 1732 - 1740.
35. Kobayashi, N., Kuramoto, T., Yamaoka, K., Hashida, M., Takakura, Y. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther 2001 ; 297: 853 - 860.
36. Oh, YK, Kim, JP, Hwang, TS, Ko, JJ, Kim, JM, Yang, JS, et al. Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery. Vaccine 2001 ; 19: 4519 - 4525.
37. Kawabata, K., Takakura, Y., Hashida, M. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995 ; 12: 825 - 830.
38. Quezada, A., Larson, J., French, M., Ponce, R., Perrard, J., Durland, R., et al. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models. J Pharm Pharmacol 2004 ; 56: 177 - 185.
39. La Cava, A., et al. Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant. J Immunol 2000 ; 164: 1340 - 1345.
40. Dupuis, M., et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 2000 ; 165: 2850 - 2858.
41. Manam, S., et al. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Inter-virology 2000 ; 43: 273 - 281.
42. Satkauskas, S., Bureau, MF, Mahfoudi, A., Mir, LM Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol Ther 2001 ; 4: 317 - 323.
43. Miller, DG, Adam, MA, Miller, AD Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990 ; 10: 4239 - 4242.
44. Zi, XY, et al. Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice. Eur J Immunol 2006 ; 36: 875 - 86.
45. Haley, P. Species differences in the structure and function of immune system. Toxicology 2003 ; 188: 49 - 71.
46. DiPasquale, L., Hayes, W. Repeated dose toxicity. In: Hayes, W, (ed), Principles and methods of toxicology. 4 th ed. Philadelphia: Taylor and Francis ; 2001: 959 - 1000.
47. Greaves, P. Histopathology of preclinical toxicity studies. Interpretation and relevance in drug safety evaluation. 2 nd ed. Elsevier, Amsterdam, The Netherlands; 2000.